Tsumura & Co - Company Profile
Powered by 
All the sales intelligence you need on Tsumura & Co in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Tsumura & Co fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Tsumura & Co.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Tsumura & Co (Tsumura) is a traditional pharmaceuticals developer that markets Kampo extract intermediates and granular Kampo formulations. The company's product portfolio comprises a range of prescription Kampo products, over-the-counter (OTC) Kampo formulations, crude drug pieces, and raw materials for crude drugs. The company's Kampo products are used to treat diseases that are difficult to treat with Western drugs, such as abdominal pain and bloating, diseases specific to women, cramps, acne, muscle spasms, lower back pain, respiratory diseases and cardiovascular diseases. The company has a business presence in the US, China, and Japan. Tsumura is headquartered in Minato-ku, Tokyo, Japan.
Headquarters
Japan
Address
2-17-11, Akasaka, Minato, Tokyo, 107-8521
Website
www.tsumura.co.jp
Telephone
81 3 63617200
No of Employees
4,923
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
4540 (TYO)
Revenue (2025)
$1.2B
6.4%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
-13.3%
(2025 vs 2024)
Market Cap*
$1.8B
Net Profit Margin (2025)
XYZ
-18.5%
(2025 vs 2024)
* As of and is in US$
Tsumura & Co premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Products | Service | Tsumura |
| Prescription Kampo | Logistics Services | KAMPOmics |
| Daiokanzoto Extract Granules: Constipation, Abdominal Bloating, Hemorrhoid, Acne | ||
| XYZ | ||
| XYZ | ||
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In June, the company entered into an agreement to acquire Shanghai Hongqiao Traditional Chinese Drug Pieces. |
| 2023 | New Products/Services | In December, the company launched General Chinese Herbal Medicine K-Chat. |
| 2023 | Contracts/Agreements | In November, the company and Yubari Tsumura announced a collaboration with Iwate Prefecture employment support facility for persons with disabilities to commence the production of medicinal crops. |
Competitor Comparison
| Key Parameters | Tsumura & Co | Yakult Honsha Co Ltd | Taisho Pharmaceutical Holdings Co Ltd | Sawai Group Holdings Co Ltd | Hisamitsu Pharmaceutical Co Inc |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Minato | Minato-Ku | Toshima | Yodogawa | Chiyoda-Ku |
| State/Province | Tokyo | Tokyo | Tokyo | Osaka | Tokyo |
| No. of Employees | 4,923 | 2,912 | 8,784 | 3,630 | 2,759 |
| Entity Type | Public | Public | Private | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Terukazu Kato | Director; Chief Executive Officer; President | Executive Board | 2019 | 63 |
| Kei Sugii | Director; Co-Chief Operating Officer | Executive Board | 2022 | 57 |
| Akito Imada | Chief Technology Officer; Head - Research & Development Division; Executive Officer | Senior Management | 2026 | 57 |
| Kaoru Kobayashi | Head - Corporate Management Division; Chief Financial Officer; Executive Officer | Senior Management | - | - |
| Toshio Yamaoka | Executive Officer; Head - Pharmaceutical Sales & Marketing Division | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer